Smith; Lianne

Patent Applications and Registrations

Patent applications and USPTO patent grants for Smith; Lianne.The latest application filed is for "composition and methods for treatment of ornithine transcarbamylase deficiency".

Company Profile

7.8.14

Smith; Lianne - Lexington MA
Smith; Lianne - Cambridge MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Composition and Methods for Treatment of Ornithine Transcarbamylase Deficiency App 20220072152 - Askew; Kim ; et al.	2022-03-10
MRNA therapy for argininosuccinate synthetase deficiency Grant 11,224,642 - Heartlein , et al. January 18, 2	2022-01-18
Composition and methods for treatment of ornithine transcarbamylase deficiency Grant 11,167,043 - Askew , et al. November 9, 2	2021-11-09
Messenger Rna Therapy For The Treatment Of Ornithine Transcarbamylase Deficiency App 20210205421 - DeRosa; Frank ; et al.	2021-07-08
Synergistic Enhancement of the Delivery of Nucleic Acids via Blended Formulations App 20200390797 - DeRosa; Frank ; et al.	2020-12-17
Messenger RNA therapy for the treatment of ornithine transcarbamylase deficiency Grant 10,835,583 - DeRosa , et al. November 17, 2	2020-11-17
Synergistic enhancement of the delivery of nucleic acids via blended formulations Grant 10,646,504 - DeRosa , et al.	2020-05-12
Cftr Mrna Compositions And Related Methods And Uses App 20200046752 - Heartlein; Michael ; et al.	2020-02-13
CFTR MRNA compositions and related methods and uses Grant 10,420,791 - Heartlein , et al. Sept	2019-09-24
Synergistic Enhancement of the Delivery of Nucleic Acids via Blended Formulations App 20190216843 - DeRosa; Frank ; et al.	2019-07-18
Composition and Methods for Treatment of Ornithine Transcarbamylase Deficiency App 20190192688 - Askew; Kim ; et al.	2019-06-27
Messenger Rna Based Viral Production App 20190127708 - Heartlein; Michael ; et al.	2019-05-02
Synergistic enhancement of the delivery of nucleic acids via blended formulations Grant 10,130,649 - Derosa , et al. November 20, 2	2018-11-20
Cftr Mrna Compositions And Related Methods And Uses App 20180015116 - Heartlein; Michael ; et al.	2018-01-18
Messenger RNA Therapy for the Treatment of Ornithine Transcarbamylase Deficiency App 20180008680 - DeRosa; Frank ; et al.	2018-01-11
CFTR mRNA compositions and related methods and uses Grant 9,713,626 - Heartlein , et al. July 25, 2	2017-07-25
Synergistic Enhancement Of The Delivery Of Nucleic Acids Via Blended Formulations App 20160151409 - Derosa; Frank ; et al.	2016-06-02
Messenger Rna Based Viral Production App 20160122727 - Heartlein; Michael ; et al.	2016-05-05
Cftr Mrna Compositions And Related Methods And Uses App 20160106772 - Heartlein; Michael ; et al.	2016-04-21
CFTR mRNA compositions and related methods and uses Grant 9,181,321 - Heartlein , et al. November 10, 2	2015-11-10
Mrna Therapy For Argininosuccinate Synthetase Deficiency App 20150110859 - Heartlein; Michael ; et al.	2015-04-23
Cftr Mrna Compositions And Related Methods And Uses App 20150038556 - Heartlein; Michael ; et al.	2015-02-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.